InvestorsHub Logo
Followers 2
Posts 2974
Boards Moderated 0
Alias Born 06/23/2017

Re: None

Thursday, 11/09/2017 11:10:01 PM

Thursday, November 09, 2017 11:10:01 PM

Post# of 44784
Many here seem to think that this company follows many in the industry when it comes to raises. Of course they do. Limited financing options, expensive trials, extremely ling time roi. But many seem to forget the other norm in this industry. Dilute, dilute, dilute...reverse split. Yes just sit back calmly, they got the best technology, in great hands. Ya right.

Someone just posted an article talking about the possibilities with Pluristem and the possibilities when it comes to CLI. I tried looking for it but couldn't find it. It mentioned about a different CLI product that showed great potential in phase 2, but not in phase 3. There is an much increased risk, when it comes to phase 3 trials that nobody would want to think about. We have, in essence, a phase 1/2 trial in CLI, with no placebo control. All comparisons based on previous results from other studies.

There is a reason that phase 3 trial success is even harder to obtain successful results. There is next to no evidence, that any Pluristem phase 3 trials will give the results that everyone is wanting/expecting. That is why the success rate from 2 to 3 drops by a extremely large percentage. Nobody talks about that, just we have the best product...period! Not yet by any means, just great potential. And enormous risk, especially with the twin clowns running the ship.

Someone mentioned quite brilliantly, that this raise is the last at these levels. No way we will ever get a raise of that sort, if indeed we start dwindling the cash, going to these useless shows. Nobody is going to pony up anything in the $1's to watch them yet again, blow through cash like we have with the 30% dilution we had in one year, when expectations are so high, and deliverance is at a snails pace.

The "newbie" to the group states they "must" be a capable management team, or we wouldn't have been able to get us to where we are. Correct. They had a vision and took us to where we are. They have there place in history. But they are INCAPABLE of getting us to the next level. Same dang level for 7 years when it comes to stock price. Sure progression in trials etc is great. That's what companies do. But to just keep diluting to get us to this stage, puts a bad taste in people's mouths who have just invested a large sum of money into this stock like they did pre-raise in Israel.

That taste of the $1.30's we had today must have felt horrible for most until we came back some. Well don't feel so relieved. There were a lot of U.S. buyers recently that would have no problem cutting losses and chalk it up to a lesson learned when it comes to the twins. And I'm sure the Israeli investors are happy with a 15% haircut. They know this is their last raise without an unbelievable dilution. That is why the secretive ATM disclosure from the end of the quarter to the release of the quarter. Better get it while you can management...cause this is your last chance!!!

I have never wanted to be wrong more in my life. If I am, feel free to attack and make fun of me as much as you want. I will gladly put my tail between my legs, and bow down to the cheerleaders on this board. Nothing I would love more.